<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7935855/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Summary of the results of the phase I PRS-based analyses of the genetic sharing between PD and the blood levels of 370 lipids and lipid-related molecules.</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">Lipid class</th>
   <th colspan="1" rowspan="1" id="0-1-.">Lipid sub-class</th>
   <th colspan="1" rowspan="1" id="0-2-.">Total number of lipids</th>
   <th colspan="1" rowspan="1" id="0-3-.">Number of lipids with 
    <i>P</i> &lt; 1.93E-05 
   </th>
   <th colspan="1" rowspan="1" id="0-4-.">Number of lipids with 
    <i>R</i>
    <sup>2</sup> &gt; 1% 
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td rowspan="2">Fatty acyls</td>
   <td>Fatty acids</td>
   <td>60</td>
   <td>4</td>
   <td>0</td>
  </tr>
  <tr>
   <td>AC</td>
   <td>23</td>
   <td>4</td>
   <td>1</td>
  </tr>
  <tr>
   <td rowspan="4">Glycerolipids</td>
   <td>Metabolism</td>
   <td>2</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>MAG</td>
   <td>4</td>
   <td>1</td>
   <td>0</td>
  </tr>
  <tr>
   <td>DAG</td>
   <td>4</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>TAG</td>
   <td>47</td>
   <td>4</td>
   <td>2</td>
  </tr>
  <tr>
   <td rowspan="6">Glycerophospholipids</td>
   <td>PC aa</td>
   <td>37</td>
   <td>1</td>
   <td>0</td>
  </tr>
  <tr>
   <td>PC ae</td>
   <td>36</td>
   <td>3</td>
   <td>0</td>
  </tr>
  <tr>
   <td>LPC</td>
   <td>14</td>
   <td>3</td>
   <td>1</td>
  </tr>
  <tr>
   <td>LPE</td>
   <td>6</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>LPI</td>
   <td>3</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>Inositol metabolism</td>
   <td>3</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>Sphingolipids</td>
   <td>SM</td>
   <td>10</td>
   <td>2</td>
   <td>1</td>
  </tr>
  <tr>
   <td rowspan="3">Sterols</td>
   <td>CE</td>
   <td>11</td>
   <td>1</td>
   <td>1</td>
  </tr>
  <tr>
   <td>Cholesterol</td>
   <td>3</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>Other</td>
   <td>12</td>
   <td>1</td>
   <td>0</td>
  </tr>
  <tr>
   <td rowspan="5">Lipoproteins</td>
   <td>HDL</td>
   <td>24</td>
   <td>1</td>
   <td>0</td>
  </tr>
  <tr>
   <td>IDL</td>
   <td>6</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>LDL</td>
   <td>16</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>VLDL</td>
   <td>32</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>Apolipoproteins</td>
   <td>2</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td rowspan="2">Others</td>
   <td>Bile acid metabolism</td>
   <td>11</td>
   <td>0</td>
   <td>0</td>
  </tr>
  <tr>
   <td>Others</td>
   <td>4</td>
   <td>0</td>
   <td>0</td>
  </tr>
 </tbody>
 <tfoot>
  <p>
   <i>AC</i> acylcarnitine, 
   <i>MAG</i> monoacylglycerol, 
   <i>DAG</i> diacylglycerol, 
   <i>TAG</i> triacylglycerol, 
   <i>PC</i> phosphatidylcholine, 
   <i>PD</i> Parkinson’s disease, 
   <i>aa</i> diacyl, 
   <i>ae</i> acyl-alkyl, 
   <i>LPC</i> lysophosphatidylcholine, 
   <i>LPE</i> lysophosphatidylethanolamine, 
   <i>LPI</i> lysophosphatidylinositol, 
   <i>SM</i> sphingomyelin, 
   <i>CE</i> cholesterol ester, 
   <i>HDL</i> high-density lipoprotein, 
   <i>IDL</i> intermediate-density lipoprotein, 
   <i>LDL</i> low-density lipoprotein, 
   <i>VDLD</i> very-low-density lipoprotein. 
  </p>
  <p>Listed are the total number of lipid species examined per lipid class, the number of lipids that show Bonferroni-corrected significant genetic sharing ( 
   <i>P</i> &lt; 1.93E-05) with PD for at least one SNP 
   <i>P</i> value threshold ( 
   <i>P</i>
   <sub>T</sub>), and the number of lipids for which genetic variants associated with PD explain &gt;1% of the variance ( 
   <i>R</i>
   <sup>2</sup>) in blood levels. In total, we found 25 lipids displaying significant genetic sharing with PD. 
  </p>
 </tfoot>
</table>
